Jeffrey A. Spaeder, M.D., is Chief Medical and Scientific Officer for Quintiles. In this role, Dr. Spaeder serves as Quintiles' lead medical expert, representing the company's position on a wide variety of governance, ethical and scientific issues. He chairs Quintiles’ Drug Safety Committee, serves as vice-chair of Quintiles’ Council on Research Ethics, and provides guidance on strategic scientific initiatives.
Prior to joining Quintiles, Dr. Spaeder served in increasingly senior roles within the biopharmaceutical industry at Takeda and Abbott Laboratories and was previously a cardiologist at Johns Hopkins Hospital. He has performed research in personalized medicine and novel uses of telemedicine, and holds U.S. patents for medical applications of advanced technologies, telemedicine and information systems.
Dr. Spaeder is a graduate of the Pennsylvania State University and the Johns Hopkins University School of Medicine. He also holds a master of business administration (MBA) degree from the Kellogg School of Management at Northwestern University with a concentration in finance. He is a Fellow of the American College of Cardiology and was a Diplomate in cardiovascular disease with the American Board of Internal Medicine.